Thursday, July 30, 2026

Firm Concentration Drives a 70-Case Top Tier

Firm concentration, rather than dispersed single-case activity, drove the day’s heaviest mass-tort intake as Depo-Provera Products Liability Litigation (3140) added 21 complaints, with Anapol Weiss filing 12 and Messerli Kramer and Storms Dworak LLC jointly appearing on four. Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (3060) followed with 20 filings led by Singleton Schreiber LLP’s seven and Johnson Law Group’s three, while Uber Technologies, Inc., Passenger Sexual Assault Litigation (3084) drew 17 complaints through Cutter Law PC’s five and Levin Simes LLP’s four. Social Media Adolescent Addiction Personal Injury Products Liability Litigation (3047) added seven cases, with Rosen Injury Lawyers filing two and Frantz Law Group APLC one, as Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation (2738) logged five filings split between The Robinson Law Firm Prof Corp and Trammell PC, with two each. See the full filing feed and firm-level breakdowns here.

Social-Media Study Tests Depression-Signal Evidence

A July 29 online-ahead-of-print publication used a large language model to identify depressive expression in Weibo posts during emergencies, adding a current evidence marker for Social Media Adolescent Addiction Personal Injury Products Liability Litigation (3047). The researchers associated elevated depressive expression with perceived susceptibility and severity, anxiety, sadness, and self-focused attention, while identifying psychological resilience as protective. By converting platform posts into hourly indicators, the study spotlights the divide between algorithmically inferred expression and a clinical diagnosis of injury. That divide goes directly to expert proof in the litigation, where data-derived mental-health signals must be distinguished from individualized causation evidence.

NEC Cohort Adds Formula-Feeding Risk Evidence

A July 28 online-ahead-of-print prospective cohort study found formula feeding independently associated with heightened necrotizing enterocolitis risk among 627 low-birth-weight neonates, adding a current scientific record to Abbott Laboratories, et al., Preterm Infant Nutrition Products Liability Litigation (3026). The research also identified preeclampsia, oligohydramnios, intraventricular hemorrhage, jaundice, dehydration, and delayed feeding as predictors. That record connects formula exposure to the disease while placing it alongside material maternal and neonatal risk factors. Counsel litigating product-specific causation will have to distinguish the formula-feeding association from those competing clinical pathways.